Thymosin Alpha-1

10 × vials

A 28-amino-acid immune-modulating peptide. Studied as a T-cell and natural-killer-cell activator in immunosuppressed or viral-chronic cohorts.

$999.90

$699.90

Save $300.00

Pay for 7 vials, receive 10 — $69.99 per vial instead of $99.99.

Every pack earns rewards points · free shipping over $100

Buy a single vial Research guide

About Thymosin Alpha-1

Thymosin Alpha-1 is the 28-amino-acid immunoregulatory peptide isolated from the thymus gland. It’s one of the most-studied immune-modulating peptides in clinical research, with formal approvals for hepatitis B and C in 35+ countries and ongoing investigation in oncology, sepsis, and post-COVID recovery. The mechanism that keeps it in the immunology literature: Thymosin Alpha-1 upregulates TLR-9 signaling on dendritic cells, shifts naive T-cells toward Th1 differentiation, and restores natural-killer-cell cytotoxicity in immunosuppressed models. It’s not an immunostimulant in the naive sense — it’s an immune-system normalizer. IF the research cohort is immunosuppressed, chronically viral, or recovering from acute immune stress, THEN Thymosin Alpha-1 is the peptide with the deepest clinical-evidence base. SO it belongs in hepatitis, sepsis-recovery, oncology-adjunct, and chronic-infection research protocols. Batch-verified ≥99% HPLC.

Specifications

CAS number: 62304-98-7
Molecular formula: C129H215N33O55
Molecular weight: 3108.30 g/mol
Purity: >99% HPLC
Form: Lyophilized powder
Storage: Store at 2–8°C

For laboratory research use only. Not for human or veterinary use.